Jonathan Webster
@LeukDocWebster
Followers
172
Following
9
Media
1
Statuses
16
Assistant Professor of Oncology, Division of Hematologic Malignancies, Leukemia Group, Johns Hopkins University
Baltimore, MD
Joined November 2021
Congratulations to our fellows (@SaumyaMaruMDPhD, Neha Verma, @mnakazawa7, Nazila Shafagati, Daniel Shu, @michaelconroy, Jesse Handler) on their @ConquerCancerFd #ASCOYIA awards and former fellow and current @hopkinskimmel Asst. Prof. Eric Christenson for the #ASCOCDA!
2
7
38
Congratulations @ANiranjanAzadi #OslerPride
Congratulations to one of our great Hospitalists @ANiranjanAzadi who was just named Physician of the Year for the @SocietyHospMed MD Chapter!
0
4
22
An incredible amount of work with really brilliant people made #BMTCTN1703 a success and the new SOC for #GvHD prophylaxis #PTCyRules #BMTCTN @CIBMTR Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis | NEJM
nejm.org
In patients undergoing allogeneic hematopoietic stem-cell transplantation (HSCT), a calcineurin inhibitor plus methotrexate has been a standard prophylaxis against graft-versus-host disease (GVHD)....
22
93
231
Congratulations to the graduating class of 2023! We are so proud of you, we love you, and we will miss you. You are all going to do great things!
0
9
58
0
0
10
Great article from @NicholasShortMD and colleagues with important implications for MRD monitoring in Ph+ ALL and our understanding of the fundamental biology underlying Ph+ ALL vs de novo lymphoid blast crisis of CML vs ?Ph+ ALL with CML-like biology.
👉👉Our new paper in @AjHematology on #MRD in Ph+ #ALL. High rates of discordance between NGS for IG/TR and PCR for BCR::ABL1. High sensitivity NGS MRD may be superior to PCR and identifies PCR+ pts with low risk of relapse. Important implications for MRD monitoring in Ph+ ALL.
1
0
6
@DrChrisHourigan presenting words of wisdom from our great mentor Judy Karp at the #ASH22 AML education session.
0
8
40
Embargo lifted! Congratulations to our @HopkinsHeme trainees who were awarded ASH Abstract Achievement Awards!! 🌟Michael Hochman @mjhochman, Chief Heme Fellow @Hopkins_HemOnc 🌟Macy Early @macy_early, ASH Med Student PS Awardee 🌟 Jayla Scott, Hopkins Woodrow Wilson Awardee 🧵
6
5
52
Congratulations to Dr. @kamarroneMD on receipt of a multi-year career development award from @LUNGevity to study neoadjuvant immunotherapy and targeted therapy for surgical lung cancer harboring a #kras mutation! https://t.co/GBrtqPqI6j
19
10
105
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease | Leukemia
nature.com
Leukemia - Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease
0
0
2
We are happy to share @DrAndyMatthews work on: Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia. Thx @SelinaLugerMD @ParalkarLab and UPenn leukemia team https://t.co/VpIBgoKDKh
4
30
92
Live action footage of https://t.co/Ao8A96N3Bf arrival at #ASCO2022 Huge AML MRD dataset to present on Tuesday - but also the hoping to use this time away to write the paper...
1
3
24
Working on a podcast to highlight women pioneers in leukemia. Who do you want to hear from? Also, please re-tweet 👍
44
63
176
Clonal Hematopoiesis in Donor May Improve Bone Marrow Transplant Outcome. Great work from @LukaszPGondek
1
1
7
Like my decision to join Twitter, this article has been many years in the making. @Dr_BDSmith
https://t.co/0a1ND2V2Vr
0
1
10